Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AST

Asterias Biotherapeutics, Inc. (AST)

Asterias Biotherapeutics Common Series A
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AST
DateTimeSourceHeadlineSymbolCompany
1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
08/23/20177:00AMGlobeNewswire Inc.Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar StudyAMEX:ASTAsterias Biotherapeutics Common Series A
08/17/20178:49AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ASTAsterias Biotherapeutics Common Series A
08/14/20175:09PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ASTAsterias Biotherapeutics Common Series A
08/14/20174:10PMGlobeNewswire Inc.Asterias Biotherapeutics Reports Second Quarter Financial Results and Reviews Recent Clinical Progress and Corporate Developm...AMEX:ASTAsterias Biotherapeutics Common Series A
08/14/20177:00AMGlobeNewswire Inc.Asterias Announces Major AST-VAC2 Development Milestone: First cGMP-Compliant Lot Successfully Manufactured to Support First ...AMEX:ASTAsterias Biotherapeutics Common Series A
08/09/20177:00AMGlobeNewswire Inc.Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical TrialAMEX:ASTAsterias Biotherapeutics Common Series A
08/08/20177:00AMGlobeNewswire Inc.Former Quadriplegic Enrolled in Asterias’ SCiStar Study to Throw Ceremonial First Pitch at Major League Baseball GameAMEX:ASTAsterias Biotherapeutics Common Series A
08/07/20177:00AMGlobeNewswire Inc.Asterias Biotherapeutics to Present at Canaccord Genuity Growth Conference on August 10, 2017AMEX:ASTAsterias Biotherapeutics Common Series A
08/03/20177:00AMGlobeNewswire Inc.Asterias Biotherapeutics Opens Two Additional Clinical Sites for AST-OPC1 SCiStar StudyAMEX:ASTAsterias Biotherapeutics Common Series A
07/31/20177:00AMGlobeNewswire Inc.Asterias Biotherapeutics to Report Second Quarter Results on August 14, 2017AMEX:ASTAsterias Biotherapeutics Common Series A
07/17/20177:00AMPR Newswire (US)Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-A 20 Million Cell CohortAMEX:ASTAsterias Biotherapeutics Common Series A
07/12/20177:00AMPR Newswire (US)Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell CohortAMEX:ASTAsterias Biotherapeutics Common Series A
07/10/20177:00AMPR Newswire (US)Asterias Biotherapeutics Receives FDA Clearance to Enroll C-4 Patients in SCiStar StudyAMEX:ASTAsterias Biotherapeutics Common Series A
06/28/20174:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
06/28/20174:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
06/28/20174:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
06/28/20174:01PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ASTAsterias Biotherapeutics Common Series A
06/23/20175:10PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:ASTAsterias Biotherapeutics Common Series A
06/16/20175:01PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ASTAsterias Biotherapeutics Common Series A
06/13/20178:00AMPR Newswire (US)Patients with Complete Paralysis Show Additional Recovery of Arm, Hand and Finger Function at 9-months After Treatment with A...AMEX:ASTAsterias Biotherapeutics Common Series A
06/08/20177:00AMPR Newswire (US)Asterias Biotherapeutics to Present New 9-Month Efficacy Data from AST-OPC1 SCiStar Study at the International Society for St...AMEX:ASTAsterias Biotherapeutics Common Series A
06/07/20174:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
06/07/20174:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
06/07/20174:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ASTAsterias Biotherapeutics Common Series A
05/23/20175:08PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:ASTAsterias Biotherapeutics Common Series A
05/23/20175:01PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ASTAsterias Biotherapeutics Common Series A
05/23/20174:10PMPR Newswire (US)Asterias Biotherapeutics Announces Top Leadership TransitionAMEX:ASTAsterias Biotherapeutics Common Series A
05/15/20175:02PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ASTAsterias Biotherapeutics Common Series A
05/11/20175:06PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ASTAsterias Biotherapeutics Common Series A
 Showing the most relevant articles for your search:AMEX:AST